http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111912982-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4724
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111912982-B
titleOfInvention Application of galectin-3 in diagnosis, treatment and prognosis of liver cancer bone metastasis
abstract The invention belongs to the technical field of biotechnology, and particularly relates to application of galectin-3 in diagnosis, treatment and prognosis of liver cancer bone metastasis. The galectin-3 is used as a diagnosis, treatment and prognosis target in the liver cancer bone metastasis, and the application of a reagent for detecting the expression level of the galectin-3 in preparing a diagnosis, treatment and prognosis reagent in the liver cancer bone metastasis is also provided. The galectin-3 promotes the liver cancer bone metastasis by promoting the differentiation and maturation of osteoclast precursors, can predict the risk of bone metastasis of patients, and achieves the effect of preventing the bone metastasis. Compared with the existing detection kit which can only detect after bone metastasis occurs, the galectin-3 can predict the occurrence of liver cancer bone metastasis in an early stage, diagnose the liver cancer bone metastasis, predict the disease progress, evaluate the treatment effect, guide the use of medicaments and evaluate the prognosis more characteristically and sensitively, and can be used as a target for treating the bone metastasis.
priorityDate 2020-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID786492
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16854
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557373
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1664388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3958

Total number of triples: 20.